AtriCure (ATRC) Tops Q1 EPS by 3c, Reiterates Prior Guidance For FY 2017
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $28.44 --0%
EPS Growth %: +92.3%
Financial Fact:
Revenue: 38.34M
Today's EPS Names:
DTGI, CRMT, MAYS, More
EPS Growth %: +92.3%
Financial Fact:
Revenue: 38.34M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
AtriCure (NASDAQ: ATRC) reported Q1 EPS of ($0.32), $0.03 better than the analyst estimate of ($0.35). Revenue for the quarter came in at $41.3 million versus the consensus estimate of $40.3 million.
For earnings history and earnings-related data on AtriCure (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Goldman Sachs Assumes Klaviyo Inc (KVYO) at Buy
- Tech eyes recovery after selloff, Micron to report results - What’s moving markets
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
